National Institute of Neurology & Neurosurgery, Havana - LAENALS Affiliate Site

Research
Multi-Condition · Serves ALS/MND

Havana, Cuba

Research
Overall Score
3.0 / 5.0
3 of 6 dimensions scored · 3 N/A
How is this score calculated?

Score by Dimension

Services Breadth
3/5
Advocacy Reach
N/A
Accessibility
2/5
Patient Support
N/A
Data Completeness
4/5
Network Connectivity
N/A
3 of 6 dimensions scored · 3 marked N/A (excluded from the average).
Auto-imported

Score breakdown

Services Breadth

3/5

Number of service categories this organization offers.

  • ✓1 service category listed

Advocacy Reach

How broadly this organization advocates and informs the ALS community.

  • —Raises ALS awareness
  • —Online information source
  • —Publishes research / reports
  • —International reach
  • —Engages in policy / advocacy

Accessibility

2/5

How easy it is for patients and families to reach this organization.

  • —Has website
  • ✓Has phone number
  • —Has email
  • —Has street address
  • ✓Has map coordinates

Patient Support

Breadth of direct support offered to patients and families.

  • —In-person support groups
  • —Online support groups
  • —Caregiver resources in services
  • —Funds or provides home care
  • —Children's resources

Data Completeness

4/5

Percentage of profile fields with information.

  • ✓Name
  • ✓Type
  • ✓Country
  • ✓State / region
  • —Address
  • ✓Phone
  • —Email
  • —Website
  • ✓Mission

Network Connectivity

Connections to research consortia and ALS networks.

  • —Part of a consortia
  • —International reach
  • —Publishes research
  • —Maintains an ALS database
  • —Mentions a known network (NEALS, ENCALS, TRICALS, etc.)

Mission

Cuba's flagship national neurological institute; LAENALS founding member country institution; **lowest documented ALS prevalence in the Americas** (0.55/100,000 in 2018). LAENALS founding country institution — Cuba is one of three founding LAENALS countries Lowest documented ALS prevalence in the Americas — 0.55 per 100,000 in 2018 (crude prevalence, adult population aged 15+) Lowest annual ALS incidence in LAENALS — 0.195 per 100,000 in 2018 Median survival from onset: 29 months (15-42.5 IQR) — between Chile and Uruguay 49 Cuban ALS patients included in LAENALS 2017-2019 cohort (55.1% men; mean age at onset 60.21 ± 12.45 years)

Services
ALS Research and Data Sources

Community Reviews

Be the first to share your experience.

Is this your organization?

Claim this listing to verify your information and unlock premium features.

Subscribe to ALS Compass

Your weekly guide to ALS resources, research, and community.

Free. Unsubscribe anytime.

Have firsthand experience with National Institute of Neurology & Neurosurgery, Havana - LAENALS Affiliate Site?